ArticleJournal of biomedical science2026

AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model.

Elisa Pagliari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.